Germany vs Norway: Estimated antiretroviral therapy coverage among people living with HIV
Germany
91.0%
in 2024
Norway
90.0%
in 2023
Germany rank
15th
Norway rank
18th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Germany
- Norway
How they compare
Germany currently reports 91.0% against 90.0% in Norway, a difference of 1.0%.
The two have swapped places 1 time across 11 shared years of data; in 2010 it was Norway ahead.
Germany ranks 15th and Norway ranks 18th of 143 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.9% | 74.0% | 4.9% | Germany |
| 2020s | 92.0% | 90.0% | 2.0% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Germany or Norway?
- Germany, at 91.0% against 90.0% in Norway as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Germany and Norway?
- 1.0%, with Germany ahead.
- How many years of comparable data are there for Germany and Norway?
- 11 years are reported by both, from 2010 to 2023.
- How do Germany and Norway rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Germany ranks 15th and Norway ranks 18th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.